B

Boundless Bio

68 employees

Boundless Bio is a precision oncology company developing therapeutics directed against extrachromosomal DNA (ecDNA) in aggressive cancers.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Therapeutics
Life Science

Date founded

2018

Funding rounds raised

Total raised

$105M

from 20 investors over 20 rounds

B

Boundless Bio raised $100M on May 16, 2023

Investors: Nextech Invest, Sectoral Asset Management, Partner Fund Management, Redmile Group, Leaps by Bayer, Surveyor Capital, Vertex Ventures HC, Logos Global Management, LP, RA Capital Management, L.P. and Wellington Management

B

Boundless Bio raised $105M on April 28, 2021

Investors: Nextech Invest, Partner Fund Management, Wellington Management, Logos Global Management, LP, Surveyor Capital, Redmile Group, Vertex Ventures HC and RA Capital Management, L.P.

B

Boundless Bio raised $46M on September 19, 2019

Investors: ARCH Venture Partners and City Hill Ventures

FAQ